Session Name: Poster Session A: Xenotransplantation
Session Type: Poster Session
Date: Saturday, May 30, 2020
Session Time: 3:15pm-4:00pm
Presentation Time: 3:30pm-4:00pm
*Purpose: Porcine vascular endothelial cells (PECs) play a central role in xeno-recognition and costimulation. The objectives of this study were to characterize the immuno-phenotype of human T cells in response to primary cultured PECs, and to explore the immuno-modulating effects of mTOR blockade of T cells and/or PECs during xenogenic immuno-responses.
*Methods: Primary cultured PECs, isolated from aorta, were used as stimulators. In selected experiments, PECs were pre-treated with 10 ng/mL of rapamycin for 72 hours before stimulation. Human peripheral blood mononuclear cells were obtained from normal individuals and labeled with VPD-450 followed by stimulation with PECs monolayers for 6 days with inhibitors specific for mTOR, B7, and CD11a. Cells were analyzed by flow cytometry to detect cell proliferation. An intracellular cytokine staining (ICCS) assay was performed to detect xeno-specific memory cell responses to PEC following 12 hours stimulation.
*Results: ICCS assay did not detect significant memory T cells responses following PECs stimulation as determined by lack of TNF-α and IFN-γ producing cells. The proliferation of T cells in response to PECs were detected (CD4+ 11.6±2.6%, CD8+ 24.3±6.06%). Phenotypically, the proliferating CD4+ cells composed with a significant higher fraction of CD57+PD1+ (p=0.01) and CD57–PD1+ (p=0.00377) subsets when compared with non-proliferating cells, and the frequency of effector memory (CD45RA–CCR7–) subset in proliferating cells was significantly higher than non-proliferating cells (p=0.0062). Similarly, a dramatic increase of CD57–PD1+ cells was also revealed in proliferating CD8+ cells (p=0.006) when compared with non-proliferating cells. These proliferating cells were largely effector memory cells. Belatacept partially inhibited xeno-specific T cell proliferation (CD4+ 62.4±17%, CD8+ 50±222.4%). The presence of rapamycin during xenogeneic immune responses produced partial inhibitory effects (CD4+ 62.96±17%, CD8+ 63.8±15.8%). CD11a blockade only achieved minimal inhibition. In contrast, PECs, pre-treated with rapamycin, were unable to induce xenogeneic T cell proliferation with 95% inhibitory effects on both CD4+ and CD8+ cells.
*Conclusions: Our study did not observe xeno-specific memory T cell-mediated immune responses to PEC. Xenogenic PECs induced primed T cell proliferation characterized by increased fraction of PD1 expressing cells and effector memory subset. Xenogenic T cell proliferation is inhibited by belatacept and rapamycin but not CD11a blockade. Rapamycin pre-treated PECs exhibit a dramatic inhibitory effect in reducing xeno-specific T cell proliferation suggesting a direct role for rapamycin to alter PEC xeno-immunogenicity leading to inhibition of xeno-specific immune response.
To cite this abstract in AMA style:Li S, Kirk A, Xu H. Immuno-Modulation of Primed Xenogeneic T Cell Response by mTOR Blockade of T Cells and Porcine Endothelial Cells [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/immuno-modulation-of-primed-xenogeneic-t-cell-response-by-mtor-blockade-of-t-cells-and-porcine-endothelial-cells/. Accessed December 1, 2023.
« Back to 2020 American Transplant Congress